SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories gets two observations for Unit 2 at Pashmylaram

10 Feb 2020 Evaluate

The United States Food and Drug Administration (USFDA) has inspected one of the Manufacturing facilities of Neuland Laboratories (Unit 2), located at Pashmylaram, Patancheru Mandal, Sangareddy District, from February 3-7, 2020.

The inspection has been completed with two observations given under form 483, which are procedural in nature. The company has already initiated corrective and preventive actions for the observations and is confident of satisfying the FDA within the stipulated time.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Neuland Laboratories Share Price

16971.70 768.65 (4.74%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×